1 documents found
Information × Registration Number 0115U001870, R & D request Title Multicenter, randomized, double-blind study phase 3 to assess the tolerability and pharmacokinetics of use roflumilastu 500 mg once daily in the mode of dose escalation in chronic obstructive pulmonary disease (COPD) with an open period of dose reduction to assess the tolerability and pharmacokinetics of use roflumilast 500 mg once daily Head Бойко Микола Григорович, Registration Date 11-09-2015 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
Multicenter, randomized, double-blind study phase 3 to assess the tolerability and pharmacokinetics of use roflumilastu 500 mg once daily in the mode of dose escalation in chronic obstructive pulmonary disease (COPD) with an open period of dose reduction to assess the tolerability and pharmacokinetics of use roflumilast 500 mg once daily
Head: Бойко Микола Григорович. Multicenter, randomized, double-blind study phase 3 to assess the tolerability and pharmacokinetics of use roflumilastu 500 mg once daily in the mode of dose escalation in chronic obstructive pulmonary disease (COPD) with an open period of dose reduction to assess the tolerability and pharmacokinetics of use roflumilast 500 mg once daily. Ukrainian medical stomatological Academy. № 0115U001870
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку